Homebiotech

biotech

biotech

Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression

Jim Cornall - May 1, 2026

biotech

ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma

Jim Cornall - April 30, 2026

biotech

Aragen launches India’s first women-led chemistry synthesis laboratory

Jim Cornall - April 30, 2026

biotech

Vaccine strategy induces broadly neutralising HIV antibodies

Jim Cornall - April 30, 2026

biotech

Lilly injectable medicine and device manufacturing facility to be built in Pennsylvania

Jim Cornall - February 2, 2026

biotech

A broken DNA repair tool accelerates aging

Jim Cornall - February 2, 2026

biotech

Base to Base biotech podcast 44: Treating breast cancer and how a CDMO and immuno-oncology company collaborate

Jim Cornall - January 30, 2026

biotech

Two-faced nanoparticles help antibiotics treat resistant bacteria

Jim Cornall - January 29, 2026

biotech

Resolve M Therapeutics exits from stealth

Jim Cornall - January 29, 2026

biotech

New cancer treatment options through expanding ADC payload spectrum

Jim Cornall - January 29, 2026

biotech

Why tumours become aggressive and genetically unstable

Jim Cornall - January 28, 2026

biotech

DIA launches platform to boost drug development

Jim Cornall - January 28, 2026

1...202122...73 Page 21 of 73

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression

Jim Cornall - May 1, 2026 0

This week, our conversations are with Uwe Diegel, CEO of Lifeina, about their cooling technologies, and with Dirk Beher, CEO of FundaMental Pharma, about...

ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma

biotech Jim Cornall - April 30, 2026 0

Aragen launches India’s first women-led chemistry synthesis laboratory

biotech Jim Cornall - April 30, 2026 0

Vaccine strategy induces broadly neutralising HIV antibodies

biotech Jim Cornall - April 30, 2026 0

New target for cancer treatment

biotech Jim Cornall - April 29, 2026 0